Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac

Background. A meningococcal group A conjugate vaccine, PsA-TT (MenAfriVac), developed through the Meningitis Vaccine Project and manufactured by the Serum Institute of India, Ltd, was tested in multiple clinical trials conducted mainly in Africa. The impact of age at which subjects were vaccinated o...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Infect Dis
Hoofdauteurs: Tang, Yuxiao, Plikaytis, Brian D., Preziosi, Marie-Pierre, Borrow, Ray
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2015
Onderwerpen:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639503/
https://ncbi.nlm.nih.gov/pubmed/26553685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ601
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items